Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-11-091372
Filing Date
2011-04-07
Accepted
2011-04-07 17:10:39
Documents
11
Period of Report
2011-04-07

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d6k.htm 6-K 11074
2 ANNUAL REPORT dex991.htm EX-99.1 1116645
3 GRAPHIC g161568g19w84.jpg GRAPHIC 7254
4 GRAPHIC g161568g24y83.jpg GRAPHIC 20659
5 GRAPHIC g161568g42o49.jpg GRAPHIC 4470
6 GRAPHIC g161568g70z16.jpg GRAPHIC 6355
7 GRAPHIC g161568g75a99.jpg GRAPHIC 7270
8 GRAPHIC g161568g78e73.jpg GRAPHIC 8378
9 GRAPHIC g161568g78e78.jpg GRAPHIC 4291
10 GRAPHIC g161568g91g08.jpg GRAPHIC 7332
11 GRAPHIC g161568g92h46.jpg GRAPHIC 6539
  Complete submission text file 0001193125-11-091372.txt   1230037
Mailing Address 210 - 1167 KENSINGTON CRES NW CALGARY A0 T2N 1X7
Business Address 1167 KENSINGTON CRES NW SUITE 210 CALGARY ALBERTA CANADA T2N 1X7 ALBERTA CANADA A0 00000 4036707380
ONCOLYTICS BIOTECH INC (Filer) CIK: 0001129928 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 000-31062 | Film No.: 11746839
SIC: 2834 Pharmaceutical Preparations